Your browser doesn't support javascript.
loading
Acquired BRAF Rearrangements Induce Secondary Resistance to EGFR therapy in EGFR-Mutated Lung Cancers.
Vojnic, Morana; Kubota, Daisuke; Kurzatkowski, Christopher; Offin, Michael; Suzawa, Ken; Benayed, Ryma; Schoenfeld, Adam J; Plodkowski, Andrew J; Poirier, John T; Rudin, Charles M; Kris, Mark G; Rosen, Neal X; Yu, Helena A; Riely, Gregory J; Arcila, Maria E; Somwar, Romel; Ladanyi, Marc.
Afiliación
  • Vojnic M; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Kubota D; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Kurzatkowski C; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Offin M; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Suzawa K; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Benayed R; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Schoenfeld AJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Plodkowski AJ; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Poirier JT; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Rudin CM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York.
  • Kris MG; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York.
  • Rosen NX; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Yu HA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York.
  • Riely GJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York.
  • Arcila ME; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Somwar R; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Ladanyi M; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: ladanyim@mskcc.org.
J Thorac Oncol ; 14(5): 802-815, 2019 05.
Article en En | MEDLINE | ID: mdl-30831205
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Resistencia a Antineoplásicos / Proteínas Proto-Oncogénicas B-raf / Receptores ErbB / Adenocarcinoma del Pulmón Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Thorac Oncol Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Resistencia a Antineoplásicos / Proteínas Proto-Oncogénicas B-raf / Receptores ErbB / Adenocarcinoma del Pulmón Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Thorac Oncol Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos